75 related articles for article (PubMed ID: 3425462)
1. Studies on anti-viral mucosal immunity with the lipoidal amine adjuvant avridine.
Anderson AO; Wood OL; King AD; Stephenson EH
Adv Exp Med Biol; 1987; 216B():1781-90. PubMed ID: 3425462
[No Abstract] [Full Text] [Related]
2. Enhanced murine respiratory tract IgA antibody response to oral influenza vaccine when combined with a lipoidal amine (avridine).
Bergmann KC; Waldman RH
Int Arch Allergy Appl Immunol; 1988; 87(3):334-5. PubMed ID: 3203969
[TBL] [Abstract][Full Text] [Related]
3. Mucosal priming alters pathogenesis of Rift Valley fever.
Anderson AO; Snyder LF; Pitt ML; Wood OL
Adv Exp Med Biol; 1988; 237():717-23. PubMed ID: 3254072
[No Abstract] [Full Text] [Related]
4. Efficacy of avridine as an adjuvant for Newcastle disease virus antigen in chickens.
Rweyemamu MM; Umehara O; de Lucca-Neto D; Baltazar MC; Vicente FE; Medeiros-Neto Rda R
Am J Vet Res; 1986 Jun; 47(6):1243-8. PubMed ID: 3729124
[TBL] [Abstract][Full Text] [Related]
5. Mucosal antibody response of calves after oral and intrabronchial administration of rotavirus.
van Zaane D; IJzerman J; de Leeuw PW
Adv Exp Med Biol; 1987; 216B():1855-62. PubMed ID: 2827448
[No Abstract] [Full Text] [Related]
6. Efficacy of three candidate Rift Valley fever vaccines in sheep.
Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
[TBL] [Abstract][Full Text] [Related]
7. Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine.
Zhang X; Zhang X; Yang Q
Vaccine; 2007 Apr; 25(17):3254-62. PubMed ID: 17303292
[TBL] [Abstract][Full Text] [Related]
8. Enhanced mucosal priming by cholera toxin and procholeragenoid with a lipoidal amine adjuvant (avridine) delivered in liposomes.
Pierce NF; Sacci JB
Infect Immun; 1984 May; 44(2):469-73. PubMed ID: 6370867
[TBL] [Abstract][Full Text] [Related]
9. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant.
Fatunmbi OO; Newman JA; Sivanandan V; Halvorson DA
Vaccine; 1992; 10(9):623-6. PubMed ID: 1502840
[TBL] [Abstract][Full Text] [Related]
11. Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.
Lorenzo G; Rodríguez-Pulido M; López-Gil E; Sobrino F; Borrego B; Sáiz M; Brun A
Antiviral Res; 2014 Sep; 109():64-7. PubMed ID: 24973761
[TBL] [Abstract][Full Text] [Related]
12. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
13. Immune response of steers, goats and sheep to inactivated Rift Valley Fever vaccine.
Yedloutschnig RJ; Dardiri AH; Walker JS; Peters CJ; Eddy GA
Proc Annu Meet U S Anim Health Assoc; 1979; (83):253-60. PubMed ID: 298921
[No Abstract] [Full Text] [Related]
14. Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens.
Tseng LP; Chiou CJ; Chen CC; Deng MC; Chung TW; Huang YY; Liu DZ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):285-9. PubMed ID: 19439366
[TBL] [Abstract][Full Text] [Related]
15. Role of mucosal antibodies in viral infections.
Kato H; Kato R; Fujihashi K; McGhee JR
Curr Top Microbiol Immunol; 2001; 260():201-28. PubMed ID: 11443875
[No Abstract] [Full Text] [Related]
16. Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.
Bracci L; Canini I; Puzelli S; Sestili P; Venditti M; Spada M; Donatelli I; Belardelli F; Proietti E
Vaccine; 2005 Apr; 23(23):2994-3004. PubMed ID: 15811645
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
18. Studies on the development of a vaccine against bovine ephemeral fever.
Theodoridis A; Boshoff SE; Botha MJ
Onderstepoort J Vet Res; 1973 Sep; 40(3):77-82. PubMed ID: 4788558
[No Abstract] [Full Text] [Related]
19. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
[TBL] [Abstract][Full Text] [Related]
20. Further comparison of adjuvants for an inactivated infectious coryza vaccine.
Blackall PJ
Avian Dis; 1988; 32(4):831-5. PubMed ID: 3202776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
